![Wilfred A. Jefferies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wilfred A. Jefferies
Fundador en MYND LIFE SCIENCES INC. .
Fortuna: 196 471 $ al Hoy
Cargos activos de Wilfred A. Jefferies
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MYND LIFE SCIENCES INC. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | 26/11/2020 | - | |
Fundador | 06/07/2018 | - | |
Presidente | 26/11/2020 | 04/12/2023 | |
University of British Columbia | Corporate Officer/Principal | - | - |
Michael Smith Laboratories
![]() Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
CAVA Healthcare, Inc.
![]() CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Presidente | - | - |
Director Técnico/Científico/I+D | - | - | |
Eyam Vaccines & Immunotherapeutics Ltd. | Presidente | - | - |
Director Técnico/Científico/I+D | - | - | |
Fundador | - | - |
Historial de carrera de Wilfred A. Jefferies
Antiguos cargos conocidos de Wilfred A. Jefferies.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NEVIS BRANDS INC. | Fundador | 28/01/2011 | - |
Corporate Officer/Principal | 28/01/2011 | - | |
Synapse Technologies, Inc.
![]() Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Fundador | - | - |
MARKER THERAPEUTICS, INC. | Presidente | - | 31/08/2009 |
Director Técnico/Científico/I+D | - | - |
Formación de Wilfred A. Jefferies.
University of Victoria | Undergraduate Degree |
Sir William Dunn School of Pathology | Doctorate Degree |
Estadísticas
Internacional
Canadá | 7 |
Estados Unidos | 3 |
Reino Unido | 2 |
Operativa
Chairman | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 4 |
Sectorial
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Synapse Technologies, Inc.
![]() Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Michael Smith Laboratories
![]() Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Commercial Services |
CAVA Healthcare, Inc.
![]() CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
MYND Life Sciences, Inc. | |
Eyam Vaccines & Immunotherapeutics Ltd. |
- Bolsa de valores
- Insiders
- Wilfred A. Jefferies
- Experiencia